These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5745194)

  • 1. [Isoxsuprine as a uterine muscle relaxant. I. In threatened abortion].
    Cucinella N; Di Grigoli D; Giambanco V
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1511-5. PubMed ID: 5745194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoxsuprine as a uterine muscle relaxant. II. In threatened premature labor].
    Cucinella N; Giambanco V; Di Grigoli D
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1516-22. PubMed ID: 5745195
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of isoxsuprine in the treatment of threatened abortion].
    Massobrio M; Sismondi P; Capra A; Campagnoli C
    Minerva Ginecol; 1969 Nov; 21(22):1570-6. PubMed ID: 5393543
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of threatened abortion and premature labor with isoxsuprine hydrochloride].
    Scillieri P; Grossi F
    Arch Ostet Ginecol; 1971; 76(4):129-37. PubMed ID: 5153115
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical trial of isoxsuprine in the treatment of threatened abortion.
    Bigby MA; Barnard EE; Chatterji S
    J Obstet Gynaecol Br Commonw; 1969 Oct; 76(10):934-5. PubMed ID: 5386835
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of isoxsuprine in threatened premature labor].
    Ruggeri E
    Attual Ostet Ginecol; 1968; 14(2):161-71. PubMed ID: 5754080
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical contribution on the use of delayed-action isoxsuprine in threatened abortion].
    Sola O; Colonna-Romano L
    Arch Ostet Ginecol; 1974; 79(5-6):326-35. PubMed ID: 4471560
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1974 Jan; 96(2):55-8. PubMed ID: 4606038
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isoxsuprine chlorhydrate in the treatment of threatened abortion].
    Ballestrin L
    Arch Ostet Ginecol; 1973; 78(1-3):53-66. PubMed ID: 4614770
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of isoxsuprine hydrochloride in the therapy of threatened abortion].
    CHIERI S; MAFFEO G
    Minerva Ginecol; 1962 Jul; 14():689-93. PubMed ID: 14020812
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of threatening premature deliveries by traniquilizers--alone or in combination with analgin].
    Stoianov S; Tsvetkov T
    Akush Ginekol (Sofiia); 1969; 8(3):214-9. PubMed ID: 5363220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of isoxsuprine hydrochloride in threatened abortion].
    Cazzola D
    Quad Clin Ostet Ginecol; 1967 Jun; 22(6):382-96. PubMed ID: 5628977
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interpretative analysis of 50 cases of tocolysis treated with isoxsuprine].
    Tomassini A; Razzini M; Zocchi G; Caprioli E
    Minerva Ginecol; 1975 Nov; 27(11):861-73. PubMed ID: 1103019
    [No Abstract]   [Full Text] [Related]  

  • 14. Hexamethonium chloride and apresoline in toxemia of pregnancy; a preliminary report.
    ASHE JR; THOMAS WL
    Obstet Gynecol; 1955 Mar; 5(3):325-40. PubMed ID: 14356592
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the use of isoxysuprine in threatened abortion].
    Julitta A; Bonito L; Fornaroli G
    Minerva Ginecol; 1969 Jul; 21(13):867-8. PubMed ID: 5398492
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interactions between beta-mimetics and indices of feto-placental function].
    Forcucci-Zulli M; Moggian G; Pini PL
    Minerva Ginecol; 1985 Mar; 37(3):89-92. PubMed ID: 4022442
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
    Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
    Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of pentolinium tartrate with and without hydralazine in the treatment of severe hypertension.
    PERRY HM; SCHROEDER HA
    N Engl J Med; 1955 Jun; 252(25):1057-66. PubMed ID: 14383963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of threatened abortion and premature delivery with Duvadilan and Dilatol].
    Hengst P; Neumann H
    Z Arztl Fortbild (Jena); 1971 Aug; 65(16):850-4. PubMed ID: 4946946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Control of uterine contraction with tocolytic agents (ritodrine). 2. Use in cases of threatened abortion, cervical incontinence and gynecologic surgery in pregnancy].
    Colombo PA; Pittino R; Pascalino MC; Quaranta S
    Ann Ostet Ginecol Med Perinat; 1981; 102(6):431-40. PubMed ID: 7337350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.